Just 2 weeks from TODAY, a fortnight.
Oral Presentation Details:
Presentation Title: Phase 1/2 Trial of AXO-AAV-GM1 Gene Therapy for the Treatment of Infantile- and Juvenile-onset GM1 Gangliosidosis
Presentation Number: OR28
Session: Session 4a: CNS & Sensory II
Presenting Author: Erica De Boever, Ph.D., DDS, MPH, Vice President of Clinical Development at Sio Gene Therapies
Presentation Date and Time: Thursday October 21, 2021; 9:00-11:00 AM CEST
Presentation Title: Bicistronic AAV Gene Therapy for Tay-Sachs and Sandhoff Diseases in a Sheep Model
Presentation Number: OR30
Session: Session 4a: CNS & Sensory II
Presenting Author: Toloo Taghian, Ph.D., University of Massachusetts
Presentation Date and Time: Thursday, October 21, 2021; 9:00-11:00 AM CEST
Poster Presentation Details:
Presentation Title: Phase 1/2 Open-label Dose Evaluation Study of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease: Efficacy, Safety, and Tolerability Data up to 24 Months
Poster Number: P254
Presenting Author: Gavin Corcoran, MD, Chief R&D Officer of Sio Gene Therapies
Good luck and GOD bless,